The upregulation of SDF1 or CXCR4 has been observed to mitigate muscle atrophy and enhance muscle fiber diameter, suggesting that the activation of the CXCR4 pathway could potentially counteract muscle wasting observed in cancer [61]. Here, CXCL12 is linked to cancer.